# Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

> **NCT06130059** · PHASE2 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Heart Failure
- Inflammation

## Interventions

- **DRUG:** Low Dose Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06130059
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-24
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06130059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06130059, "Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06130059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*